Oklahoma Cancer Specialists and Research Institute /ID# 269527 — Tulsa, Oklahoma

Oklahoma Cancer Specialists and Research Institute /ID# 269527 is a clinical research site located in Tulsa, Oklahoma, United States 74146.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Oklahoma Cancer Specialists and Research Institute /ID# 269527 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tulsa

Browse all research sites in Oklahoma · View every site in Tulsa

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma Cancer Specialists and Research Institute /ID# 269527?

Oklahoma Cancer Specialists and Research Institute /ID# 269527 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma Cancer Specialists and Research Institute /ID# 269527 conducted?

Oklahoma Cancer Specialists and Research Institute /ID# 269527 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is Oklahoma Cancer Specialists and Research Institute /ID# 269527 accredited by Crixeo Clinical Trials?

Oklahoma Cancer Specialists and Research Institute /ID# 269527 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma Cancer Specialists and Research Institute /ID# 269527?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.